MedTrace Logo

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

NCT02218801 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 219

Last updated 2022-05-31

No results posted yet for this study

Summary

This prospective database has two main objectives;

* to evaluate the complication rates, 30-day and 90-day mortality from different surgical strategies for unresectable, borderline resectable or initially unresectable liver metastasis from colorectal cancer.
* to establish baseline quality parameters for different surgical strategies for unresectable, borderline and initially unresectable colorectal liver metastasis (CRLM) patients.

Conditions

  • Liver Metastasis
  • Colorectal Carcinoma

Interventions

OTHER

Evaluation of treatment for liver metastasis

Sponsors & Collaborators

  • European Society of Surgical Oncology

    collaborator OTHER

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Serge Evrard, Prof. · Institut Bergonié

  • Graeme Poston, Prof. · Aintree University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2020-01-31
Completion
2021-02-28

Countries

  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Netherlands
  • Serbia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02218801 on ClinicalTrials.gov